Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sabra Healthcare REIT ( (SBRA) ) has provided an update.
In the second quarter of 2025, Sabra Health Care REIT reported a net income of $0.27 per diluted share and announced several strategic investments, including a $53 million acquisition of a senior housing property. The company also transitioned 21 senior housing properties to new operators, aiming to enhance asset value. Sabra closed a $500 million unsecured term loan to refinance existing debt, reducing interest costs. The company updated its 2025 earnings guidance, reflecting positive trends in Medicare and Medicaid reimbursement rates, which are expected to support its skilled nursing portfolio. Sabra’s liquidity stood at $1.2 billion as of June 30, 2025, and the company declared a quarterly dividend of $0.30 per share.
The most recent analyst rating on (SBRA) stock is a Hold with a $16.00 price target. To see the full list of analyst forecasts on Sabra Healthcare REIT stock, see the SBRA Stock Forecast page.
Spark’s Take on SBRA Stock
According to Spark, TipRanks’ AI Analyst, SBRA is a Outperform.
Sabra Healthcare REIT shows strong financial performance and a positive earnings outlook, supported by strategic corporate actions. However, valuation concerns and technical indicators suggest caution.
To see Spark’s full report on SBRA stock, click here.
More about Sabra Healthcare REIT
Sabra Health Care REIT, Inc. operates in the healthcare real estate investment trust industry, focusing on investments in skilled nursing facilities, senior housing communities, behavioral health facilities, and specialty hospitals across the United States and Canada.
Average Trading Volume: 2,590,823
Technical Sentiment Signal: Strong Buy
Current Market Cap: $4.35B
For an in-depth examination of SBRA stock, go to TipRanks’ Overview page.